Hepatic fas antigen expression before and after interferon therapy in patients with chronic hepatitis C (original) (raw)
References
Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233–243, 1991 PubMed Google Scholar
Nagata S: Fas and Fas ligand: A death factor and its receptor. Adv Immunol 57:129–144, 1994 PubMed Google Scholar
Anel A, Buferne M, Boyer C, Schmit-Verhulst A-M, Golstein P: T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur J Immunol 24:2469–2476, 1994 PubMed Google Scholar
Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169–1178, 1993 PubMed Google Scholar
Searle J, Harmon BV, Bishop CJ, Kerr JFR: The significance of cell death by apoptosis in hepatobiliary disease. J Gastroenterol Hepatol 2:77–96, 1987 Google Scholar
Schupper H, Hayashi P, Scheffel J, Aceituno S, Paglieroni T, Holland PV, Zeldis JB: Peripheral-blood mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C. Hepatology 18:1055–1060, 1993 PubMed Google Scholar
Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD: Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 149:3339–3344, 1992 PubMed Google Scholar
Hiramatsu N, Hayashi N, Katayama K, Mochizuki K, Kawanishi Y, Kasahara A, Fusamoto H, Kamada T: Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19:1354–1359, 1994 PubMed Google Scholar
Yousuf M, Nakano Y, Tanaka E, Sodeyama T, Kiyosawa K: Persistence of viremia in patients with type-C chronic hepatitis during long-term follow-up. Scand J Gastroenterol 27:812–816, 1992 PubMed Google Scholar
Desmet VJ, Gerber M, Hoofnagel JH, Manns M, Scheuer PJ: Classification of chronic hepatitis: Diagnosis, grading, and staging. Hepatology 19:1513–1520, 1994 PubMed Google Scholar
Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol chloroform extraction. Anal Biochem 162:156–159, 1987 PubMed Google Scholar
Kanai K, Iwata K, Nakao M, Okamoto H: Suppression of hepatitis C virus RNA by interferon a. Lancet 336:245, 1990 Google Scholar
Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, Machida A, Mishiro S, Yoshizawa H, Miyakawa Y, Mayumi M: Detection of hepatitis C virus by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med 60:215–222, 1990 PubMed Google Scholar
Kwok S, Higuchi R: Avoiding false positives with PCR. Nature 339:237–238, 1989 PubMed Google Scholar
Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M: Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J Gen Virol 73:673–679, 1992 PubMed Google Scholar
Hino K, Okuda M, Konishi T, Ishiko H, Okita K: Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-α. Dig Dis Sci 40:14–20, 1995 PubMed Google Scholar
Koji T, Kobayashi N, Nakanishi Y, Yoshii A, Hashimoto S, Shibata Y, Anjiki N, Yamamoto R, Aoki A, Ueda T, Kanazawa S, Nakane PK: Immunohistochemical localization of Fas antigen in paraffin sections with rabbit antibodies against human synthetic Fas peptides. Acta Histochem Cytochem 27:459–463, 1994 Google Scholar
Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS: Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74:2391–2399, 1993 PubMed Google Scholar
Hoofnagle JH, Mullen KD, Jones DB, Rustgi V, Bisgeglie AD, Peters M, Waggoner JG, Park Y, Jones EA: Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon; A preliminary report. N Engl J Med 315:1575–1578, 1986 PubMed Google Scholar
Lowin B, Hahne M, Mattmann C, Tschoop J: Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370:650–652, 1994 PubMed Google Scholar
Cohen JJ, Duke CD, Fadok VA, Sellines KS: Apoptosis and programmed cell death in immunity. Annu Rev Immunol 10:267–293, 1992 PubMed Google Scholar
Trauth BC, Klas C, Peters AMJ, Matzku S, Moller P, Falk W, Debatin KM, Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301–305, 1989 PubMed Google Scholar
Kobayashi N, Hamamoto Y, Yamamoto N, Ishii A, Yonehara M, Yonehara S: Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc Natl Acad Sci USA 87:9620–9624, 1990 PubMed Google Scholar
Falk MH, Trauth BC, Debatin KM, Klas C, Gregory CD, Rickinson AB, Calender A, Lenoir GM, Ellwart JW, Krammer PH, Bornkamm GW: Expression of APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype. Blood 79:3300–3306, 1992 PubMed Google Scholar
Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747–1756, 1989 PubMed Google Scholar
Owen-Schaub LB, Yonehara S, Crump III WL, Grimm EA: DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 140:197–205, 1992 PubMed Google Scholar
Mita E, Hayashi N, Iio S, Takehara T, Hijioka T, Kasahara A, Fusamoto H, Kamada T: Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem Biophys Res Comm 204:468–474, 1994 PubMed Google Scholar
Tanaka M, Suda T, Takahashi T, Nagata S: Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 14:1129–1135, 1995 PubMed Google Scholar